Showing results (721-730 of 938) with videos related to
Sort By:
Pageof 94
Neuropharmacology|August 1, 1986
MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal areaA J Bradbury, B Costall, P G Jenner, et al.Neuroscience Letters|April 10, 1987
Modulation of the long-latency reflex to stretch by the supplementary motor area in humansJ P Dick, J C Rothwell, B L Day, et al.The Journal of Pharmacy and Pharmacology|August 10, 2000
In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenesN S Perry, P J Houghton, A Theobald, et al.Genomics|January 1, 1993
Evidence for locus heterogeneity in autosomal dominant torsion dystoniaF Ahmad, M B Davis, H M Waddy, et al.Clinical Neuropharmacology|August 1, 1996
Botulinum toxin in the treatment of writer's crampN Turjanski, Z Pirtosek, J Quirk, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1994
Unusual focal dyskinesias: the ears, the shoulders, the back, and the abdomenJ N Caviness, A Gabellini, C S Kneebone, et al.Brain : a Journal of Neurology|April 1, 1992
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's diseaseV M Mann, J M Cooper, D Krige, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?H Meierkord, D R Fish, S J Smith, et al.The Journal of Physiology|September 1, 1991
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in manY Ugawa, B L Day, J C Rothwell, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1976
Bromocriptine treatment in Parkinson's diseaseJ D Parkes, C D Marsden, I Donaldson, et al.Pageof 94